Truist Financial Corp Glaukos Corp Transaction History

Truist Financial Corp

  • $62.7 Billion
  • Q4 2024

A detailed history of Truist Financial Corp transactions in Glaukos Corp stock. As of the latest transaction made, Truist Financial Corp holds 7,370 shares of GKOS stock, worth $927,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,370
Previous 12,689 41.92%
Holding current value
$927,735
Previous $1.65 Million 33.15%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$126.42 - $152.67 $672,427 - $812,051
-5,319 Reduced 41.92%
7,370 $1.11 Million
Q3 2024

Nov 13, 2024
SELL
$113.62 - $135.39 $657,746 - $783,772
-5,789 Reduced 31.33%
12,689 $1.65 Million
Q2 2024

Aug 20, 2024
BUY
$89.48 - $118.35 $133,325 - $176,341
1,490 Added 8.77%
18,478 $2.19 Million
Q1 2024

May 10, 2024
SELL
$76.4 - $96.33 $690,274 - $870,341
-9,035 Reduced 34.72%
16,988 $1.6 Million
Q4 2023

Feb 02, 2024
SELL
$59.53 - $85.11 $1.22 Million - $1.74 Million
-20,495 Reduced 44.06%
26,023 $2.07 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $18,345 - $20,958
-265 Reduced 0.57%
46,518 $3.5 Million
Q2 2023

Aug 01, 2023
BUY
$45.44 - $71.21 $167,264 - $262,124
3,681 Added 8.54%
46,783 $3.33 Million
Q1 2023

May 05, 2023
BUY
$43.88 - $52.48 $286,755 - $342,956
6,535 Added 17.87%
43,102 $2.16 Million
Q4 2022

Feb 17, 2023
SELL
$40.82 - $57.75 $108,622 - $153,672
-2,661 Reduced 6.78%
36,567 $1.6 Million
Q3 2022

Oct 26, 2022
BUY
$46.84 - $58.49 $662,083 - $826,756
14,135 Added 56.33%
39,228 $2.09 Million
Q2 2022

Jul 22, 2022
BUY
$34.86 - $63.77 $5,403 - $9,884
155 Added 0.62%
25,093 $1.14 Million
Q1 2022

Apr 22, 2022
BUY
$44.33 - $57.82 $224,442 - $292,742
5,063 Added 25.47%
24,938 $1.44 Million
Q4 2021

Feb 14, 2022
SELL
$40.27 - $56.99 $113,641 - $160,825
-2,822 Reduced 12.43%
19,875 $883,000
Q3 2021

Nov 05, 2021
BUY
$47.43 - $84.23 $33,438 - $59,382
705 Added 3.21%
22,697 $1.09 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $114,046 - $152,509
1,561 Added 7.64%
21,992 $1.87 Million
Q1 2021

May 17, 2021
BUY
$70.43 - $97.42 $718,104 - $993,294
10,196 Added 99.62%
20,431 $1.72 Million
Q4 2020

Nov 19, 2021
SELL
$48.9 - $75.26 $150,220 - $231,198
-3,072 Reduced 23.09%
10,235 $770,000
Q4 2020

Feb 18, 2021
SELL
$48.9 - $75.26 $173,448 - $266,947
-3,547 Reduced 21.05%
13,307 $1 Million
Q3 2020

Nov 13, 2020
SELL
$37.23 - $50.97 $91,139 - $124,774
-2,448 Reduced 12.68%
16,854 $835,000
Q2 2020

Aug 14, 2020
SELL
$28.78 - $46.83 $113,565 - $184,791
-3,946 Reduced 16.97%
19,302 $742,000
Q1 2020

May 15, 2020
SELL
$25.53 - $70.14 $34,465 - $94,689
-1,350 Reduced 5.49%
23,248 $718,000
Q4 2019

Feb 14, 2020
BUY
$54.18 - $65.64 $1.33 Million - $1.61 Million
24,598 New
24,598 $1.34 Million

Others Institutions Holding GKOS

# of Institutions
354
Shares Held
50M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.99B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email